Pages with the fewest revisions

Jump to navigation Jump to search

Showing below up to 50 results in range #26,101 to #26,150.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. Fluocinonide Topical (patient information) (1 revision)
  2. Fluocortin (1 revision)
  3. Fluorene (1 revision)
  4. Fluorescence (1 revision)
  5. Fluorescence anisotropy (1 revision)
  6. Fluorescence correlation spectroscopy (1 revision)
  7. Fluorescence resonance energy transfer (1 revision)
  8. Fluorescent tag (1 revision)
  9. Fluoride (patient information) (1 revision)
  10. Fluoride poisoning (1 revision)
  11. Fluoride therapy (1 revision)
  12. Fluorinated ethylene propylene (1 revision)
  13. Fluorodopa F 18 (1 revision)
  14. Fluoroestradiol f 18 (1 revision)
  15. Fluorogenic (1 revision)
  16. Fluoronium (1 revision)
  17. Fluorouracil (patient information) (1 revision)
  18. Fluorouracil Topical (patient information) (1 revision)
  19. Fluoxetine detailed information (1 revision)
  20. Fluoxetine overdose (1 revision)
  21. Fluphenazine (patient information) (1 revision)
  22. Flurandrenolide Topical (patient information) (1 revision)
  23. Flurazepam (patient information) (1 revision)
  24. Flushing (physiology) (1 revision)
  25. Flutazolam (1 revision)
  26. Flutelmium (1 revision)
  27. Fluticasone Nasal Spray (patient information) (1 revision)
  28. Fluticasone Oral Inhalation (patient information) (1 revision)
  29. Fluticasone Topical (patient information) (1 revision)
  30. Fluticasone and Salmeterol Oral Inhalation (patient information) (1 revision)
  31. Fluticasone overdose (1 revision)
  32. Flutoprazepam (1 revision)
  33. Flutter valve (1 revision)
  34. Fluvastatin (patient information) (1 revision)
  35. Flux (metallurgy) (1 revision)
  36. Flybase (1 revision)
  37. Foaming agent (1 revision)
  38. Focal adhesion (1 revision)
  39. Focal length (1 revision)
  40. Focal neurologic signs (1 revision)
  41. Focal segmental glomerulosclerosis case study one (1 revision)
  42. Focal segmental glomerulosclerosis cost-effectiveness of therapy (1 revision)
  43. Focal segmental glomerulosclerosis future or investigational therapies (1 revision)
  44. Focal segmental glomerulosclerosis secondary prevention (1 revision)
  45. Foggy brain (1 revision)
  46. Foix–Alajouanine syndrome (1 revision)
  47. Folate deficiency case study one (1 revision)
  48. Folate deficiency imaging findings (1 revision)
  49. Foliate papillae (1 revision)
  50. Folic Acid overdose (1 revision)

View ( | ) (20 | 50 | 100 | 250 | 500)